Homocysteine, left ventricular dysfunction and coronary artery disease: is there a link?

Gian Paolo Rossi1, Teresa Maria Seccia, Achille Cesare Pessina

  • 1Department of Clinical and Experimental Medicine (DMCS-Internal Medicine 4), School of Medicine, University of Padua, Padua, Italy. gianpaolo.rossi@unipd.it

Insights

High plasma homocysteine (tHcy) levels predict cardiovascular death in hypertensive patients. This finding, linked to reduced left ventricular function, suggests potential benefits of tHcy-lowering treatments in coronary artery disease.

Area of Science:

  • Cardiology
  • Biochemistry
  • Clinical Research

Background:

  • Plasma total homocysteine (tHcy) is implicated in coronary artery disease (CAD).
  • Previous studies suggest a link between tHcy and cardiovascular outcomes.
  • The precise role of tHcy in hypertensive patients with CAD requires further elucidation.

Purpose of the Study:

  • To investigate the association between tHcy levels and cardiovascular mortality in hypertensive patients with CAD.
  • To explore the relationship between tHcy and left ventricular (LV) function.
  • To determine if tHcy impacts cardiovascular risk independently of established CAD markers.

Main Methods:

  • Analysis of data from the GENICA (Genetic and Environmental factors In Coronary Atherosclerosis) study.
  • Assessment of tHcy levels in relation to cardiovascular mortality and LV ejection fraction.
  • Statistical analysis to control for confounding factors like CAD severity and history of myocardial infarction.

Main Results:

  • High tHcy levels were a significant predictor of cardiovascular mortality in hypertensive patients, independent of CAD and myocardial infarction history.
  • tHcy was not associated with the extent of coronary atherosclerosis.
  • An inverse relationship was observed between tHcy levels and left ventricular ejection fraction, indicating impaired systolic function.

Conclusions:

  • Elevated tHcy is an independent risk factor for cardiovascular mortality in hypertensive CAD patients.
  • The inverse association between tHcy and LV function may explain its link to heart failure risk.
  • Further research into tHcy's effect on LV function is warranted to explore therapeutic strategies for CAD.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...